Trial intelligence / Profile preview

Plasmalyte vs Saline in Deceased Donor Kidney Transplantation

NCT03829488Phase 3Completed

Sponsor
The University of Queensland
Start
Jan 2018
Primary completion
Jul 2021
Modality
Small Molecules
Countries
2
01

Overview

Phase 3, randomised, double-blind trial of plasma-lyte in delayed graft function (DGF) (2 arms), sponsored by The University of Queensland. Primary endpoint: Delayed Graft Function at 7 days. Started Jan 2018; status: completed.

02

Drugs

plasma-lyte
03

Conditions

delayed graft function (DGF)

Beyond the preview

Go deeper on NCT03829488.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03829488.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call